Literature DB >> 14996227

Comorbidities in chronic neuropathic pain.

Bruce Nicholson1, Sunil Verma.   

Abstract

Neuropathic pain arises from a lesion or dysfunction within the nervous system; the specific mechanisms that elicit neuropathic pain symptoms are the subject of ongoing research. It is generally acknowledged that neuropathic pain is extremely difficult to treat, and a major factor impacting outcomes is the presence of comorbidities such as poor sleep, depressed mood, and anxiety. Patients who suffer from chronic pain experience difficulties in initiating and maintaining sleep. Sleep deprivation has been associated with a decreased pain threshold, muscle aches, and stiffness in normal volunteers. The interrelationship of these factors is complex: Many chronic pain patients are depressed and anxious; sleep deprivation can lead to anxiety; and depression can be both the cause and the result of sleep disturbances. Thus, physicians must evaluate all aspects of pain, sleep, and mood in chronic pain patients. Several instruments have been developed to aid physicians in gathering qualitative and quantitative information from chronic pain patients. This triad of chronic pain, sleep disturbances, and depression/anxiety must be fully addressed if the patient is to be restored to optimal functionality. A multidisciplinary team approach allows for treatment of the whole patient. Nonpharmacologic interventions include relaxation therapy, sleep restriction therapy, and cognitive therapy. Strategies for pharmacologic interventions should attempt to maximize outcomes by employing, where possible, agents that address both the pain and the comorbidities. In this way, functionality may be restored and the patient's quality of life improved. Copyright American Academy of Pain Medicine

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996227     DOI: 10.1111/j.1526-4637.2004.04019.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  66 in total

1.  WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression.

Authors:  G T Whiteside; J M Dwyer; J E Harrison; C E Beyer; T Cummons; L Manzino; L Mark; G H Johnston; B W Strassle; A Adedoyin; P Lu; M J Piesla; C M Pulicicchio; J C L Erve; B J Platt; Z A Hughes; K E Rogers; D C Deecher; E J Trybulski; J D Kennedy; P Zhang; L Leventhal
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Avoidant safety behaviors and catastrophizing: shared cognitive-behavioral processes and consequences in co-morbid pain and sleep disorders.

Authors:  Shane MacDonald; Steven J Linton; Markus Jansson-Frojmark
Journal:  Int J Behav Med       Date:  2008

Review 3.  Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Transl Res       Date:  2021-02-07       Impact factor: 7.012

4.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.

Authors:  Victoria C J Wallace; Julie Blackbeard; Andrew R Segerdahl; Fauzia Hasnie; Timothy Pheby; Stephen B McMahon; Andrew S C Rice
Journal:  Brain       Date:  2007-08-30       Impact factor: 13.501

5.  Musculoskeletal sensitization and sleep: chronic muscle pain fragments sleep of mice without altering its duration.

Authors:  Blair C Sutton; Mark R Opp
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

6.  Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

Authors:  B Hoffmann; A Garcia de Lorenzo; A Mehta; M Beck; U Widmer; R Ricci
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

7.  Topography of microglial activation in sensory- and affect-related brain regions in chronic pain.

Authors:  Anna M W Taylor; Sadaf Mehrabani; Steve Liu; Alison J Taylor; Catherine M Cahill
Journal:  J Neurosci Res       Date:  2016-08-30       Impact factor: 4.164

8.  Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour.

Authors:  F S Hasnie; V C J Wallace; K Hefner; A Holmes; A S C Rice
Journal:  Br J Anaesth       Date:  2007-05-03       Impact factor: 9.166

9.  Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain.

Authors:  M Cuneyt Ozmen; Gabriela Dieckmann; Stephanie M Cox; Ramy Rashad; Rumzah Paracha; Nedda Sanayei; Melina I Morkin; Pedram Hamrah
Journal:  Ocul Surf       Date:  2020-08-27       Impact factor: 5.033

10.  Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain.

Authors:  Victoria C J Wallace; Andrew R Segerdahl; Julie Blackbeard; Timothy Pheby; Andrew S C Rice
Journal:  Neurosci Lett       Date:  2008-10-07       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.